1157642-22-2 Usage
Uses
Used in Pharmaceutical Research:
2-(2,4-difluorophenyl)cyclopropanecarboxylic acid is utilized as a chemical entity for the exploration of its potential biological activities and pharmacological effects. Its unique structure may contribute to the development of new therapeutic agents, particularly in the context of drug discovery and design.
Used in Drug Discovery:
In the pharmaceutical industry, 2-(2,4-difluorophenyl)cyclopropanecarboxylic acid is employed as a lead compound for the identification of novel drug candidates. Its chemical properties and potential interactions with biological targets make it a valuable starting point for the synthesis of new medicinal compounds.
Used in Medicinal Chemistry:
2-(2,4-difluorophenyl)cyclopropanecarboxylic acid serves as a building block in the synthesis of complex organic molecules with potential therapeutic applications. Its reactivity and structural features can be exploited to create a variety of drug-like molecules, expanding the scope of available treatments for various diseases and conditions.
Overall, 2-(2,4-difluorophenyl)cyclopropanecarboxylic acid is a versatile chemical compound with significant potential in the development of new pharmaceuticals and therapeutic agents, warranting further investigation and research in the medical and scientific communities.
Check Digit Verification of cas no
The CAS Registry Mumber 1157642-22-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,5,7,6,4 and 2 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1157642-22:
(9*1)+(8*1)+(7*5)+(6*7)+(5*6)+(4*4)+(3*2)+(2*2)+(1*2)=152
152 % 10 = 2
So 1157642-22-2 is a valid CAS Registry Number.
1157642-22-2Relevant academic research and scientific papers
COMPLEMENT PATHWAY MODULATORS AND USES THEREOF
-
Page/Page column 72; 73, (2014/01/17)
The present invention provides a compound of formula I: (I) a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
